Thomas E. Timbie, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 50,000 shares at $20.14 ($1.0M) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Open-market sale of $1.0M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMCI | SELL | 2023-01-20 | $1.3M | — | Filing → |
| TMCI | SELL | 2022-12-16 | $1.2M | — | Filing → |
| TMCI | SELL | 2022-11-22 | $2.2M | — | Filing → |